View on Pubmed.gov 33010824 | View on doi.org 10.1016/S0140-6...
Circulating ACE2: a novel biomarker of cardiovascular risk.
- Section of Cardiovascular Imaging, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia. Electronic address: ramchaj@ccf.org.
- Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Abstract
References
Circulation. 2006 May 16;113(19):2335-62
J Am Coll Cardiol. 2008 Aug 26;52(9):750-4
Europace. 2017 Aug 1;19(8):1280-1287
BMJ. 2010 Jan 19;340:b5606
Cited by 32 citations (total)
Journal Article
The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study.
Electronic publication date April 24, 2022
Reut Kassif Lerner [...] Naomi Pode Shakked et al.
One of the major challenges for healthcare systems during the Coronavirus-2019 (COVID-19) pandemic was the inability to successfully predict which...
Journal Article
Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19.
Electronic publication date June 15, 2021
Gagandeep Kaur [...] Irfan Rahman et al.
Tobacco smoking is known to be involved in the pathogenesis of several cardiopulmonary diseases. Additionally, smokers are highly susceptible to...
Conflict of interest statement
MeSH
- •
Specialties
- •
Substances
- •